mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0003 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0004 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0004 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0005 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |